These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35862534)

  • 1. Research backing experimental Alzheimer's drug was first target of suspicion.
    Piller C
    Science; 2022 Jul; 377(6604):363. PubMed ID: 35862534
    [No Abstract]   [Full Text] [Related]  

  • 2. Research backing experimental Alzheimer's drug was first target of suspicion.
    Piller C
    Science; 2022 Jul; 377(6604):363. PubMed ID: 35862516
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug shows promise for treatment of Alzheimer's disease.
    Frankish H
    Lancet Neurol; 2006 Apr; 5(4):300. PubMed ID: 16578921
    [No Abstract]   [Full Text] [Related]  

  • 4. Tacrine for Alzheimer's.
    Handly M
    Am Pharm; 1991 Dec; NS31(12):8. PubMed ID: 1763782
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic approaches for Alzheimer's disease.
    Jahnke U
    IDrugs; 2008 Jan; 11(1):4-6. PubMed ID: 18175250
    [No Abstract]   [Full Text] [Related]  

  • 6. A small-molecule lead compound for the treatment of Alzheimer's disease.
    Doggrell SA
    Expert Opin Investig Drugs; 2005 Feb; 14(2):199-201. PubMed ID: 15757396
    [No Abstract]   [Full Text] [Related]  

  • 7. Mixed results for disease-modification strategies for Alzheimer's disease.
    Opar A
    Nat Rev Drug Discov; 2008 Sep; 7(9):717-8. PubMed ID: 19172684
    [No Abstract]   [Full Text] [Related]  

  • 8. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
    Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
    J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pazinaclone. A 77000, DN 2327.
    Drugs R D; 1999 Jul; 2(1):57-9. PubMed ID: 10610295
    [No Abstract]   [Full Text] [Related]  

  • 10. On the horizon: pathways for drug development in Alzheimer's disease.
    Hake AM; Farlow MR
    Clin Geriatr Med; 2004 Feb; 20(1):141-52. PubMed ID: 15062492
    [No Abstract]   [Full Text] [Related]  

  • 11. Acetylcholinesterase inhibitors for the treatment of dementia in Alzheimer's disease: do we need new inhibitors?
    Small DH
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):817-25. PubMed ID: 16262564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Society for Neuroscience--38th Annual Meeting--Therapeutic approaches for Alzheimer's disease, schizophrenia and bipolar disorder.
    McGee V; Whittingham P
    IDrugs; 2009 Jan; 12(1):14-6. PubMed ID: 19127498
    [No Abstract]   [Full Text] [Related]  

  • 13. Biogen's aducanumab raises hope that Alzheimer's can be treated at its source.
    Patel KR
    Manag Care; 2015 Jun; 24(6):19. PubMed ID: 26182718
    [No Abstract]   [Full Text] [Related]  

  • 14. Investigational drugs in Alzheimer's disease: current progress.
    Berk C; Paul G; Sabbagh M
    Expert Opin Investig Drugs; 2014 Jun; 23(6):837-46. PubMed ID: 24702504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ganstigmine. Chiesi.
    Johnson A
    Curr Opin Investig Drugs; 2003 Jul; 4(7):868-73. PubMed ID: 14619410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHI's Eighth Annual World Pharmaceutical Congress. Targeting Alzheimer's with novel therapeutics: Part 2.
    Yan R
    IDrugs; 2009 Aug; 12(8):482-4. PubMed ID: 19629880
    [No Abstract]   [Full Text] [Related]  

  • 17. Early investigational drugs targeting tau protein for the treatment of Alzheimer's disease.
    Anand K; Sabbagh M
    Expert Opin Investig Drugs; 2015; 24(10):1355-60. PubMed ID: 26289787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics and therapeutic prospects in Alzheimer's disease.
    Cacabelos R
    Expert Opin Pharmacother; 2005 Oct; 6(12):1967-87. PubMed ID: 16197352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site.
    Hadda TB; Talhi O; Silva ASM; Senol FS; Orhan IE; Rauf A; Mabkhot YN; Bachari K; Warad I; Farghaly TA; Althagafi II; Mubarak MS
    Mini Rev Med Chem; 2018; 18(8):711-716. PubMed ID: 28714400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New drugs for Alzheimer's disease.
    Delagarza VW
    Am Fam Physician; 1998 Oct; 58(5):1175-82. PubMed ID: 9787282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.